First Choice Medicare

We are pleased to offer Rybelsus 14 mg, the maximum-strength oral formulation of Semaglutide, in our current pharmaceutical inventory. As a pioneering glucagon-like peptide-1 (GLP-1) receptor agonist, Rybelsus is primarily indicated for the management of type 2 diabetes mellitus, working by mimicking the natural GLP-1 hormone to stimulate insulin secretion, inhibit excess glucagon release, and slow gastric emptying for superior glycemic control. This 14 mg tablet serves as the target maintenance dose for patients requiring the highest level of therapeutic efficacy, offering significant benefits in regulating blood sugar, reducing HbA1c levels, and providing secondary advantages in chronic weight management and cardiovascular risk reduction. To ensure optimal bioavailability, the medication must be taken on an empty stomach immediately upon waking with no more than 120 ml of plain water, at least 30 minutes before any food or other medications. Given its high-potency metabolic profile, Rybelsus 14 mg should be used strictly under the guidance of a healthcare professional to monitor clinical response and manage potential gastrointestinal effects.

We are engaged in Rosufree - Rosuvastatin Calcium IP 20 Mg Tablets to our clients. Our range of all products is widely appreciated by our clients.